The QualityStocks Daily Monday, September 30th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (SNNA) +73.91%

Penny Pick Finders (TCHC) +39.25%

NetworkNewsWire (ENDV) +39.13%

The QualityStocks Daily Stock List

Aleafia Health, Inc. (ALEAF)

Midas Letter, SmallCapPower, Stock Gumshoe, Proactive Investors, MicroSmallCap, Pot Stock News, InvestorsHub, New Cannabis Ventures, The Cannabis Investor, CannabisMarketCap, Stockwatch, InvestorPlace, Wallet Investor, Profit Confidential, Trading View, Technical420, Insider Financial, Stockhouse, and Simply Wall St reported previously on Aleafia Health, Inc. (ALEAF), and today we are reporting on the Company here at the QualityStocks Daily Newsletter.

Aleafia Health, Inc. operates as a vertically-integrated cannabis health and wellness company. It has four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience. The Company has ecommerce, retail distribution, and provincial supply agreements. Aleafia produces a diverse portfolio of commercially proven, high-margin derivative products. These include oils, capsules and sprays.

Aleafia Health has its corporate office in Concord, Ontario. The Company lists on the OTC Markets Group’s OTCQX. Aleafia has been named the 2019 top performing company of the year by the TSX Venture Exchange before graduation to the TSX.

Aleafia Health owns three major cannabis product and cultivation facilities. Two are licensed and operational. This includes the first large-scale outdoor cultivation facility in Canada. In addition, the Company operates the largest national network of medical cannabis clinics and education centers. These are staffed by MDs, nurse practitioners, as well as educators. Aleafia Health maintains a medical cannabis dataset with more than 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy.

Aleafia Health announced this past June that it was granted approval by Health Canada for outdoor cannabis cultivation. On June 7, 2019, its wholly-owned subsidiary Aleafia Farms, Inc., was granted a new Standard Cultivation License issued under Health Canada’s Cannabis Regulations at Aleafia’s Port Perry, Ontario facility.

In anticipation of receiving Health Canada approval, Aleafia Health dedicated growing rooms at its Paris, Ontario facility to propagate starter clones with strains particularly well-suited to outdoor cultivation. Approximately 13,000 of the starter clones are now on-site at Port Perry. The Licence allows for cannabis cultivation in Zone 1 of Aleafia’s Outdoor Grow facility, with 292,000 sq. ft. of immediate, licensed cultivation area.

Last month, Aleafia Health reported record Revenue in Q2 2019. It reported record Revenue of roughly $4.0 million. This represents an increase of 159 percent over the prior quarter. Revenue growth was mainly attributed to a strong increase in adult-use cannabis product sales, along with a 43 percent increase in Clinic Revenue.

Aleafia Health’s wholly-owned subsidiary, Aleafia Farms, has acquired the farmland directly adjacent to its Port Perry Outdoor Grow facility. This purchase will enable Aleafia to start its Outdoor Grow Phase II expansion, adding an additional 60 acres of cannabis cultivation area, for a total of 86 acres. The transaction closed on September 3, 2019, with a cash purchase price of $1.2 million.

Regarding the Port Perry Outdoor Grow facility Phase I, the expectation is that harvesting will begin at the licensed, operational 1.1 million sq. ft. outdoor cultivation facility in the next two weeks. Concerning the Port Perry Outdoor Grow Phase II Expansion, the expectation is that security and cultivation infrastructure at the 2.6 million sq. ft. expansion will be completed in November of this year. Moreover, the Niagara Greenhouse Phase I remains in a grow-ready state pending receipt of a Health Canada Cultivation Licence.

Aleafia Health, Inc. (ALEAF), closed Monday's trading session at $0.717, off by 2.977%, on 265,142 volume with 276 trades. The average volume for the last 3 months is 308,906 and the stock's 52-week low/high is $0.649999976/$3.04839992.

chart

Delrey Metals Corp. (DLRYF)

Stock Target Advisor, Street Signals, Geology for Investors, Junior Mining Network, Investing News, InvestorsHub, Mining Stock Education, Micro Small Cap, Streetwise Reports, Stockhouse, Stockwatch, InvestorX, and Investor Ideas reported previously on Delrey Metals Corp. (DLRYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Delrey Metals Corp. is working to capitalize on the increasing demand for Energy Metals. A mineral exploration company, it is concentrating on the acquisition, exploration, and development of mineral resource properties, specifically in the strategic energy minerals space. The Company has an option to earn an 80 percent interest in the Four Corners Project in Newfoundland & Labrador (NL). Delrey continues to review and acquire projects showing potential for materials used in the energy storage and electric vehicle (EV) markets. Delrey Metals has its head office in Vancouver, British Columbia.

The Company’s Four Corners Project is an advanced stage Fe-Ti-V exploration project. It has positive historic drilling, metallurgy, and development economics. Furthermore, Delrey Metals earlier acquired the Star, Porcher, Peneece, and Blackie Fe-Ti-V properties positioned along tidewater in western British Columbia.

The Four Corners Project comprises 7655.0 hectares and is located in southwestern Newfoundland and Labrador, 25km east of the town of Stephenville. The Project is host to vanadium enriched titaniferous magnetite (iron) mineralization that shows encouraging historical evidence for substantial and consistent vanadium accumulations across five main target zones.

The Blackie vanadium property is situated in west-central British Columbia, in the Skeena Mining Division, roughly 96km south-southwest (straight-line distance) from Prince Rupert. The property consists of 5 tenures covering 1213.2 Ha. It is open for expansion in manifold directions.

The Star property is in west-central British Columbia, in the Skeena Mining Division. This property consists of 4 tenures covering 3646.8 Ha and is open for expansion in manifold directions. Additionally, the Sunset Project had historical drilling done in 1991 and it totaled 393.5m over 2 holes. The target now sought at the Sunset claims is a volcanogenic massive sulphide deposit, similar to Britannia or a vein and replacement type gold-silver deposit similar to Northair or Brandywine.

The Peneece vanadium project is positioned at the head of Seymour Inlet, southwest British Columbia, This property consists of 5 tenures encompassing 1500.4 Ha. It is also open for expansion in multiple directions. The Porcher vanadium property is in west-central British Columbia, in the Skeena Mining Division. The property consists of 7 tenures covering 3122.16 Ha. It is open for expansion in numerous directions.

This past July, Delrey Metals announced plans for its 2019 drill program on its Four Corners Project, located in Newfoundland and Labrador. It plans to drill a total of 5000m from 20 drill pads at its flagship Keating Hill East Zone, which is designed to test more than 3.5km of strike length. The holes will be drilled at a spacing of approximately 300m along strike between fence lines, with two vertical drill holes per fence-line, located about 150m apart. Furthermore, the Company will be conducting follow up prospecting and sampling on its Bullseye, Four Corners, Keating Hill West, and newly discovered Keating Hill North Zones, with plans for late season drilling on the most promising targets identified.

Delrey Metals Corp. (DLRYF), closed Monday's trading session at $0.032, even for the day, on 2,000 volume with 2 trades. The average volume for the last 3 months is 24,546 and the stock's 52-week low/high is $0.021999999/$0.300000011.

chart

Fire & Flower Holdings Corp. (FFLWF)

Green Market Report, Midas Letter, New Cannabis Ventures, TipRanks, Nasdaq, Insider Financial, Stockhouse, GlobeNewswire, Investing.com, Ceo.ca, Market Screener, TradingView, Morningstar, InvestorsHub, MarketWatch, Investing News, Wallet Investor, and NIC Investors reported earlier on Fire & Flower Holdings Corp. (FFLWF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fire & Flower Holdings Corp. is a foremost purpose-built, independent adult-use cannabis retailer. It guides consumers through the complex world of cannabis via education-focused, best-in-class retailing while the Hifyre™ digital platform connects consumers with cannabis products. Fire & Flower Holdings Corp. owns all issued and outstanding shares in Fire & Flower, Inc., a licensed cannabis retailer that owns or has interests in cannabis retail store licences in the Provinces of Alberta, Saskatchewan, Manitoba, Ontario and the Yukon territory. Fire & Flower Holdings has its corporate office in Toronto, Ontario. The Company lists on the OTC Markets.

Fire & Flower Holdings leadership team combines wide-ranging experience in the cannabis industry with strong capabilities in retail operations. The Company operates as an independent retail chain that offers cannabis products and accessories to the adult-use market in Alberta and Saskatchewan. In addition, it provides brand licensing and consulting services to licensed cannabis retail stores in Ontario. Also, the Company engages in the wholesale of regulated cannabis products and accessories in Saskatchewan; and the operation of a regulated cannabis e-commerce platform.

Fire & Flower has entered into a subscription agreement regarding a strategic investment by an indirect wholly-owned subsidiary of Alimentation Couche-Tard, Inc. The Subscription Agreement allows for Couche-Tard to obtain a controlling interest in Fire & Flower with an aggregate investment of greater than $380,000,000 of growth capital for Fire & Flower's international expansion. Alimentation Couche-Tard is an international retailer with more than 16,000 stores in 26 countries.

Furthermore, Fire & Flower Holdings’ wholly-owned subsidiary, Fire & Flower, Inc. entered into asset purchase agreements with wholly-owned subsidiaries of Cannabis Cowboy, Inc. in relation to the acquisition by Fire & Flower of eight proposed cannabis retail stores under development in the Province of Alberta. All acquired locations, other than the Okotoks location, have received municipal development permits for a cannabis retail sales use. The expectation is that the Okotoks location will receive a municipal development permit soon following closing.

Last week, Fire & Flower Holdings and its wholly-owned subsidiary Fire & Flower, Inc. announced that its Chief Executive Officer, Mr. Trevor Fencott was elected to the Board of Directors of the Canadian Chamber of Commerce. As the “Voice of Canadian Business”, the Canadian Chamber of Commerce is Canada’s largest and most recognized business association in the nation. It speaks with one unified voice on behalf of almost a quarter million businesses.

Fire & Flower Holdings Corp. (FFLWF), closed Monday's trading session at $0.8932, off by 4.9787%, on 281,477 volume with 250 trades. The average volume for the last 3 months is 135,117 and the stock's 52-week low/high is $0.68959999/$1.50.

chart

Kona Gold Solutions, Inc. (KGKG)

Micro Cap Daily, Clay Trader, InvestorsHub, Wallet Investor, Wallmine, Talkmarkets, Trading View, Market Screener, 4-Traders, Discovery Stocks, Insider Financial, Stockwatch, Stockhouse, and Dividend Investor reported previously on Kona Gold Solutions, Inc. (KGKG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp and CBD (cannabidiol) lifestyle brand centered on product development in the functional beverage sector. It has formed wholly-owned subsidiaries, Kona Gold, LLC; Gold Leaf Distribution, LLC; and HighDrate, LLC. Kona Gold Solutions is based in Melbourne, Florida.

Subsidiary Kona Gold, LLC has developed a premium Hemp Infused Energy Drink line. The Gold Leaf Distribution, LLC subsidiary was established to fill Kona Gold Solutions’ distribution needs in markets it wants to quickly enter. The HighDrate, LLC subsidiary has developed the beverage industry’s first CBD Energy Water, available in four flavors.

In April 2019, Kona Gold Solutions announced it commenced production of its new Hemp Energy Drink and CBD Energy Water flavors. The Company’s Kona Gold Hemp Energy Drink line extension includes Bubble Gum and Candy Apple flavors. The line extension for its HighDrate CBD Energy Waters includes Blue Island Punch and Sour Apple.

This month, Kona Gold Solutions announced the expansion of its wholly-owned subsidiary, Gold Leaf Distribution. Gold Leaf has expanded its operations that were presently only in Florida, to South Carolina. The Company recently hired a new beverage sales person/driver, purchased a new delivery vehicle, and has expanded its product offering. Gold Leaf will now deliver products in South Carolina Territories where it formerly did not have distribution.

Furthermore, Kona Gold Solutions announced last week the national launch of its Storm CBD Water. Storm is an all new product for Kona Gold, as the Company expands its product offering in the CBD beverage market. Storm is a high alkaline water, available in 1 Liter bullet bottles. It contains 20mg of CBD isolate per bottle.

Moreover, last week, Kona Gold Solutions announced it hired a Chief Financial Officer (CFO) and Director of National Sales. The Company has experienced fast growth this year and has filled two important positions so as to maintain that growth and move the Company to higher market levels. Its new CFO, Lori Radcliffe, and Director of National Sales, Paul O'Renick, will be joining Kona Gold Solutions October 8th and October 1st respectively.

Kona Gold Solutions, Inc. (KGKG), closed Monday's trading session at $0.0765, off by 4.375%, on 2,250,645 volume with 175 trades. The average volume for the last 3 months is 3,919,369 and the stock's 52-week low/high is $0.0148/$0.149399995.

chart

Origin House (ORHOF)

NetworkNewsWire, The Seed Investor, NIC Investors, Pot Network, Wallet Investor, Pot Stock News, Trading View, Midas Letter, Investors Hub, New Cannabis Ventures, Insider Financial, Marketfy, Stockwatch, and Profit Confidential reported beforehand on Origin House (ORHOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A North American cannabis products and brands enterprise, Origin House is a firm listed on the OTCQX. The Company (previously known as CannaRoyalty Corp.) specializes in acquisitions. It is developing infrastructure to support the proliferation of its brands around the world, initially via its acquisition of Canadian retailer 180 Smoke. Origin House operates across key markets in the United States and Canada. Its strategic emphasis is on becoming a preeminent international house of cannabis brands. Origin House is based in Ottawa, Ontario.

The Company's foundation is in California, where it delivers in excess of 130 branded cannabis products from 50-plus brands to the majority of licensed dispensaries. Origin House’s brand development platform is operated out of five licensed facilities located throughout California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners.

The Company has a strong distribution network, bringing 50-plus brands to greater than 400 retailers. Origin House sees strong revenue from owned and distributed brands. The Company states that it is building a portfolio of California brands that will be in demand worldwide. While seeing robust revenue from owned and distributed brands in California, its acquired brands build its position for broader growth.

CannaRoyalty Corp. d/b/a Origin House announced in June 2019 that it obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving the plan of arrangement with Cresco Labs, Inc. previously announced on April 1, 2019 , pursuant to which, among other things, Cresco Labs intends to acquire all of the issued and outstanding common shares and class A compressed shares of Origin House. Receipt of the final order will allow Origin House to complete the Arrangement upon satisfaction of the remaining closing conditions. This includes the receipt of required regulatory approvals.

This month, Cresco Labs (CRLBF) and CannaRoyalty Corp. d/b/a Origin House, both announced that, effective September 16, 2019, they have each submitted certifications of substantial compliance with the request for additional information (Second Request) from the United States Department of Justice Antitrust Division (DOJ) in connection with Origin House’s and Cresco Labs’ notification to U.S. antitrust authorities pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as amended, in respect of Cresco Labs’ pending acquisition of Origin House.

The HSR Act waiting period was extended by the issuance of the Second Requests to Cresco Labs and Origin House. That extended waiting period terminates 30 days after considerable compliance, and the parties would be free to close unless the DOJ obtains an injunction against the transaction. The expectation is that that waiting period will expire on or around October 17, 2019. The expiration of the waiting period under the HSR Act is the last major condition to completing the Transaction. The parties are expecting to be in a position to close the Transaction following the expiration of the waiting period.

Moreover, this month, CannaRoyalty Corp. d/b/a Origin House announced that it received a further C$15 million advance of debt financing from Opaskwayak Cree Nation (OCN).

Mr. Marc Lustig , Chairman and Chief Executive Officer of Origin House, said, "We appreciate the continued support of OCN. This non-dilutive funding enables us to maintain our focus on our California growth plans while simultaneously preparing for the closing of the acquisition by Cresco Labs, upon receipt of regulatory approvals."

Origin House (ORHOF), closed Monday's trading session at $4.15, off by 7.6855%, on 401,372 volume with 1,039 trades. The average volume for the last 3 months is 222,210 and the stock's 52-week low/high is $3.70399999/$9.74699974.

chart

Silence Therapeutics plc (SLNCF)

Finance Recorder, Invest Tribune, Investors Hangout, Morningstar, Macroaxis, Dividend Investor, Proactive Investors, AI Stock Finder, Wallet Investor, and GuruFocus reported beforehand onSilence Therapeutics plc (SLNCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Silence Therapeutics plc is a leader in the discovery, development and delivery of novel RNA (Ribonucleic Acid) interference (RNAi) therapeutics for the treatment of serious diseases. The Company centers on the discovery, development, and delivery of novel RNA therapeutics in haematology, cardiovascular, as well as other rare and metabolic indications. Silence Therapeutics is based in London, the United Kingdom (UK). The Company lists on the OTC Markets.

Silence Therapeutics is developing a new generation of medicines through harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Utilizing its enabling delivery systems, Silence has achieved an additional level of specificity through delivering its therapeutic RNA molecules exclusively to target cells.

The design of its proprietary RNA chemistries and delivery systems are to improve the stability of its molecules and enhance effective delivery to target cells. This provides a strong modular technology well suited to tackle life-threatening diseases. The design of the Company’s business model is to bring solutions to patients while producing shareholder value, through translating its proprietary technology into commercial drug products in a quick and cost-effective manner.

Silence Therapeutics is developing different product candidates. These include SLN124 for the treatment of iron overload . Another is SLN360 for the reduction of cardiovascular risk, and prevention of heart attacks and cardiovascular diseases.

Mallinckrodt plc (MNK), a global biopharmaceutical company, and Silence Therapeutics announced this past July that, further to the collaboration announced earlier on July 18th, Mallinckrodt, acting through a subsidiary company, agreed to make an equity investment of $5 million in Silence Therapeutics. Immediately following admission, Mallinckrodt's shareholding represented 6.5 percent of Silence Therapeutics’ enlarged, issued share capital - 77,285,652 ordinary shares.

The separate collaboration between Mallinckrodt and Silence Therapeutics announced earlier on July 18th will enable the two companies to develop and commercialize RNAi drug targets designed to inhibit or silence the complement cascade. This is a group of proteins involved in the immune system. They play a role in the development of inflammation.

Mallinckrodt consists of numerous wholly-owned subsidiaries. These subsidiaries develop, manufacture, market and distribute specialty pharmaceutical products and therapies. Its Specialty Brands reportable segment's areas of emphasis include autoimmune and rare diseases in specialty areas such as neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company’s Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients.

Silence Therapeutics plc (SLNCF), closed Monday's trading session at $2.10, off by 7.8947%, on 38,009 volume with 11 trades. The average volume for the last 3 months is 10,339 and the stock's 52-week low/high is $0.536719977/$3.00.

chart

Tree of Knowledge International Corp. (TOKIF)

CannabisMarketCap, Penny Stock Base, New Media Wire, TipRanks, Market Screener, Stock Target Advisor, Nasdaq, TradingView, InvestorX, Morningstar, Wallet Investor, GuruFocus, Otc.watch, Investors Hangout, Stockwatch,Investing.com, Investor Ideas, MarketWatch, GlobeNewswire, Dividend Investor, Canadian Insider, Stockhouse, and InvestorsHub reported earlier on Tree of Knowledge International Corp. (TOKIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Tree of Knowledge International Corp. is driven by science-based research. The Company focuses on the development, processing, and manufacturing of high-quality cannabinoid products. It provides a range of products that include medicinals, nutraceuticals and cosmetics, as well as food, beverage and veterinary products. The Company currently has research agreements with many universities for medical cannabis research and new medical grade products development. Tree of Knowledge International (TOKI) has its headquarters in Toronto, Ontario. The Company also has operations in North York, Ontario, and Spokane, Washington.

At present, TOKI has three main business segments. One is multidisciplinary specialty pain clinics with an emphasis on the treatment of chronic pain. This includes controlled applications of medical cannabis in Canada. A second business segment is the development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane that provides formulations for TOKI’s products and for third parties equivalent to GMP standards. The third business segment is the distribution and sale of hemp-based cannabidiol (CBD) products in the USA, Canada, Europe, Brazil and Australia.

Via its Toronto Poly Clinic, TOKI has collected extensive expertise from being involved in one of the largest observational clinical trials on medical cannabis and from its continuing direct patient experience. TOKI has developed and implemented MCERP (Medical Cannabis Education, Research and Best Practice Platform) and MCORP (Medical Cannabis Opioid Reduction Program) with significant success.

The Company’s CBD product line contains EVR Premium Hemp Oil. This is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the U.S. Presently, TOKI offers a number of CBD products that may be used in connection with the treatment of several ailments and for general wellness purposes.

TOKI derives all its products from natural cannabis and hemp employing a state-of-the-art process that is as close to the source as possible. The Company has a varied team of world-class talent in the fields of education, research, evidence-based product development, GMP manufacturing, quality production, and packaging.

In August, TOKI announced that it entered into a Letter of Intent (LOI) for an investment in LYTE Clinics, to include the acquisition by TOKI of 25 percent of shares in LYTE. LYTE is a foremost medical cannabis tele-health company. It serves patients throughout nine Canadian provinces via Lyte Resource Centre. With its new Clinic in a Box initiative, Lyte has now expanded into working with several pharmacies, to help it gain access to a cannabis clinic with 5 doctors on staff and greater than 22 Licensed Producers to choose from.

Last week, TOKI announced that it and Ryerson University (Toronto) are expanding their present research project to develop a new nanotechnology-enhanced delivery method for medical cannabis and cannabinoid molecules. Added to the initial objective of creating targeted treatments for pain conditions is a pioneering application to fight cancerous tumours.

Tree of Knowledge International Corp. (TOKIF), closed Monday's trading session at $0.0388, up 17.5758%, on 30,000 volume with 1 trade. The average volume for the last 3 months is 68,788 and the stock's 52-week low/high is $0.019999999/$0.584200024.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

InvestorsHub, Morningstar, Stockopedia, Dividend Investor, Wallet Investor, Street Insider, PR Newswire, Small Cap Network, Market Screener, 4-Traders, YCharts, OTC Markets, Simply Wall St, Last10k, MarketBeat, and Stockhouse reported previously on Lixte Biotechnology Holdings, Inc. (LIXT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily centered on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical company, Lixte Biotechnology Holdings is headquartered in East Setauket, New York. The Company lists on the OTCQB.

Lixte Biotechnology has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The Company’s present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of manifold cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Furthermore, in a pre-clinical study done with scientists under collaborative research and development agreements at the National Institutes of Health, Lixte’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Consequently, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

Recently, Lixte Biotechnology announced that the first patient has been enrolled in its Phase 1b/2 study of the safety and therapeutic benefit of the Company’s lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment (NCT03886662). This study is open at Moffitt Cancer Center in Tampa, Florida. Dr. Rami Komrokji, Vice Chair of Moffitt’s Department of Malignant Hematology, is the principal investigator.

In August, Lixte Biotechnology announced that it signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de Investigación en Sarcomas, GEIS). This agreement is to support a Phase 1b/randomized Phase 2 study of doxorubicin, the international standard for the initial treatment of advanced soft tissue sarcomas (ASTS), in comparison to doxorubicin plus LB-100.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Monday's trading session at $1.35, up 22.7273%, on 2,600 volume with 6 trades. The average volume for the last 3 months is 1,586 and the stock's 52-week low/high is $0.600000023/$1.45000004.

chart

Humanigen, Inc. (HGEN)

NetworkNewsWire, TipRanks, Proactive Investors, GlobeNewswire, InvestorsHub, Insider Financial, Morningstar, Stockhouse, StreetWise Reports, 4-Traders, Trading View, Investors Hangout, Whale Wisdom, Street Insider, Equity Clock, Barchart, Proactive Investors, and Stockopedia reported previously on Humanigen, Inc. (HGEN), and today we are highlighting Company, here at the QualityStocks Daily Newsletter.

Humanigen, Inc. is developing its Humaneered® proprietary monoclonal antibodies to address critical unmet needs in today's most advanced cancer therapies. A biopharmaceutical Company, it is developing its portfolio of Humaneered® monoclonal antibodies centered on CAR-T optimization and immuno-oncology. Humaneering is a patented proprietary technology for converting suboptimal antibodies into human antibodies suitable for chronic therapies, in part, because of low immunogenicity. The Company previously went by the name KaloBios Pharmaceuticals, Inc. It changed its name to Humanigen, Inc. in August of 2017. Humanigen is based in Burlingame, California.

Derived from the Company’s Humaneered® platform, lenzilumab and ifabotuzumab, and HGEN005 are monoclonal antibodies with first-in-class mechanisms. Lenzilumab targets GM-CSF. It is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, as well as a potential treatment for hematologic cancers.

Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is being explored as a potential treatment for glioblastoma multiforme (GBM) and a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, and also as a backbone for a novel CAR-T construct, and a bispecific antibody platform.

HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.

Humanigen has announced that it entered into an exclusive worldwide license with the Mayo Clinic to certain technologies used to create CAR-T cells lacking GM-CSF expression through different gene-editing tools including CRISPR-Cas9 (GM-CSF knock-out). The license covers diverse patent applications and know-how developed by Mayo in collaboration with Humanigen. These licensed technologies complement and broaden the Company’s leadership position in the GM-CSF neutralization space and expands its discovery platform aimed at improving CAR-T to include gene-edited CAR-T cells.

Recently, Humanigen announced that it secured an exclusive worldwide license agreement from the University of Zurich (UZH) for technology used to prevent GvHD through GM-CSF neutralization. The technology was recently featured in a publication in Science Translational Medicine entitled “Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells”1. The Humanigen license encompasses varied patent applications filed by UZH that complement and broaden Humanigen’s leadership position in the application of GM-CSF and expand its development platform to include improving allogeneic HSCT.

Humanigen, Inc. (HGEN), closed Monday's trading session at $0.72, up 19.8003%, on 1,149 volume with 6 trades. The average volume for the last 3 months is 2,825 and the stock's 52-week low/high is $0.460000008/$1.54400002.

chart

Tapinator, Inc. (TAPM)

NetworkNewsWire, Zacks, TipRanks, Market Screener, Simply Wall Street, 4-Traders, Stockopedia, TradingView, Stockhouse, InvestorsHub, Wallet Investor, and TMX Money reported beforehand on Tapinator, Inc. (TAPM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Tapinator, Inc. is a developer and publisher of category leading applications (apps) for mobile platforms. The Company develops and publishes mobile games and apps on the iOS, Google Play, and Amazon platforms in North America, Europe, and Asia. Its library includes more than 300 titles that, collectively, have realized greater than 450 million mobile downloads. This includes noteworthy properties such as Video Poker Classic, Solitaire Dash, as well as Crypto Trillionaire. Established in 2013, Tapinator is based in New York, New York. The Company has product development and marketing teams located in North America, Europe, and Asia.

Tapinator generates revenues via the sale of branded advertising and through consumer transactions. This includes in-app purchases and subscriptions.

Tapinator previously announced the January 31, 2019 worldwide release of Crypto Trillionaire exclusively on Apple's iOS platform. The Company joined forces with the game's developer, Robot Cake Games of Hannover, Germany, to bring the innovative, best-in-class idle tapper game to mobile players around the world. Subsequent to its initial international launch on iOS, Crypto Trillionaire was featured by Apple as a "New Game We Love," in 152 countries, including the United States. Crypto Trillionaire is the first of a number of planned major releases for Tapinator's category-leading Games & Apps business for this year.

Tapinator announced this past April that it launched a major update to Video Poker Classic, the leading video poker game on mobile. The Company’s new 2.0 version brings multi-hand capability, a popular casino feature, to the game's core single-hand gameplay. Tapinator introduced Triple Play, Five Play, and Ten Play for all of its 39 game types. With the new version, Video Poker Classic has the richest offering of any video poker title on mobile devices, in terms of game types, gameplay formats (Single Hand, Triple Play, Five play, Ten play) and overall functionality.

Moreover, Tapinator is developing a new social casino game. The unique mobile title is scheduled for launch in Q4 of this year. The upcoming game features a slot mechanic, with inventive metagame systems, which have proven their success in the world of real money gaming. The title is made possible via the Company's recent licensing deal with a major European real-money slots developer.

The real-money version of the product is now a top performing slot game across more than 200 online casinos in several European nations. Tapinator will be announcing the details of the partnership closer to the game's launch.

Tapinator, Inc. (TAPM), closed Monday's trading session at $0.06, up 26.3158%, on 161,445 volume with 13 trades. The average volume for the last 3 months is 88,819 and the stock's 52-week low/high is $0.015499999/$0.069899998.

chart

Reliq Health Technologies, Inc. (RQHTF)

StockInvest, Emerging Growth, OTC Markets, GuruFocus, Zacks, Financial Post, Stockhouse, Business Insider, Morningstar, MarketWatch, Streetwise Reports, InvestorsHub, Barron’s, Barchart, Investors Hangout, Penny Stock Tweets, Capital Cube, and Equities reported earlier on Reliq Health Technologies, Inc. (RQHTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Reliq Health Technologies, Inc. is a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare. Its robust iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The Company formerly went by the name Moseda Technologies, Inc. It changed its name to Reliq Health Technologies, Inc. in May 2016. OTCQB-listed, Reliq Health Technologies is based in Hamilton, Ontario.

Reliq’s platform provides automated remote patient monitoring in the home. It supports secure communication between all members of the patient’s circle of care. The Company has developed a novel SaaS (Software-as-a-Service) solution for the Community Healthcare market.

The iUGO Care platform turns the patient’s home into a “virtual hospital ward” utilizing an automated two-way voice, proximity sensors, as well as biometric monitoring devices. Data collected in the home is automatically uploaded to the iUGO Care secure cloud. There, it is available to all members of the patient’s circle of care, with automated alerts if a patient’s condition starts to deteriorate. The iUGO Care platform improves medication adherence.

This past October, Reliq Health Technologies announced that it was chosen by Premier Health Group, Inc. (OTCQB: PHGRF) as its exclusive technology partner. Reliq will provide Premier’s HealthVue primary care clinics with a HealthVue-branded telemedicine, remote monitoring & artificial intelligence (AI) solution for its clinical staff and greater than 100,000 active patients.

HealthVue is a British Columbia-based wholly-owned subsidiary of Premier Health Group. HealthVue focuses on employing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and AI.

Recently, Reliq Health Technologies announced that subsequent to the closing of its Vancouver, British Columbia office, it completed key new hires and engagements to support the Company’s anticipated growth in 2019 and beyond.

Dr. Lisa Crossley, Reliq Health Technologies’ Chief Executive Officer, said, “ “We are thrilled to announce the addition of two new members of the Reliq Health leadership team and the engagement of two new key partners. Dr. Bassma Ghali has accepted the role of CTO with the company, and Mr. Lucas Smithen will take on the position of VP Products & Professional Services… The Company has also engaged Mr. Paul McCulloch to manage Reliq’s cybersecurity, privacy and policy development… Reliq has also engaged Sonique Ltd to support the Company in marketing strategy, digital & social media and creative services.”

Reliq Health Technologies, Inc. (RQHTF), closed Monday's trading session at $0.4206, up 21.913%, on 32,090 volume with 17 trades. The average volume for the last 3 months is 23,452 and the stock's 52-week low/high is $0.122299998/$0.942605972.

chart

Legacy Education Alliance, Inc. (LEAI)

TipRanks, Infront Analytics, 4-Traders, Dividend Investor, Fortune Stock Alerts, RedChip, Marketbeat, DSR News, PHUB News, Stockwatch, Stock Commander, PennyPickAlerts, and Barchart reported previously on Legacy Education Alliance, Inc. (LEAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Legacy Education Alliance, Inc. is a leading worldwide provider of practical, high-quality, and value-based educational training. This training is on the topics of personal finance, entrepreneurship, real estate, and financial markets investing strategies and techniques. The Company’s dedication is to providing quality financial education. OTCQB-listed, Legacy Educational Alliance has headquarters in the U.S., Canada, and the UK. Legacy’s U.S. office is in Cape Coral, Florida.

Legacy provides its training via a variety of brands. These include Trade Up Investor Education™; Rich Dad® Education; Rich Dad® Stock Education; Making Money from Property with Martin Roberts™; Brick Buy Brick™; Building Wealth; Robbie Fowler Property Academy™; Women in Wealth™; and The Independent Woman™.

The design of Robbie Fowler Property Academy™ is to teach investment strategies people can use to obtain a clear path towards long-term wealth.  The Independent Woman™ is a leader in the effort to provide educational training, seminars, as well as services designed to help women build their financial intelligence.

Rich Dad® Education provides students with comprehensive instruction and mentoring in real estate and financial instruments training in the U.S., Canada, and the UK. The Women In Wealth™ brand seeks to empower women with a strong financial education and help them in discovering the power of real estate investing to create cash flow and build financial independence.

The Making Money from Property with Martin Roberts™ brand provides a property-based curriculum centered on how and why to buy property at auction. The Rich Dad® Stock Education training brand helps its students become astute investors who understand how to create winning trades and potential profits in any market condition.

The Trade Up Investor Education™ brand underwent development in partnership with Investor's Business Daily®. Students’ are provided educational training designed to help them build their knowledge of stock and options trading. The Brick Buy Brick™ brand introduces its students to the tools and strategies used by successful investors to become financially free through real estate investing.

Recently, Legacy Education Alliance announced that it held a Legacy Education financial training in Hong Kong on September 15-17 in defiance of Typhoon Mangkhut.   On the days that followed the storm, most of the city’s 600 bus routes were out of service because of debris- blocked roads. Despite the chaotic transport dilemma and seemingly endless storm cleanup, students began showing up for the Legacy Education financial training.

Mr. Anthony Humpage, Legacy Education Alliance’s Chief Executive Officer, who personally attended the event, said,”…Our Hong Kong students did not let this natural disaster dictate their next steps in life. They weathered the storm, and immediately jumped back on track to becoming financially educated. Having personally witnessed super typhoon Mangkhut and its aftermath, our students’ tenacity is testament to their determination and resiliency.”

Legacy Education Alliance, Inc. (LEAI), closed Monday's trading session at $0.10, up 5.2632%, on 1,059,141 volume with 272 trades. The average volume for the last 3 months is 23,452 and the stock's 52-week low/high is $0.081/$0.35800001.

chart

Vitality Biopharma, Inc. (VBIO)

Penny Stock Tweets, Zacks, The OTC Reporter, Finance Registrar, MarketWatch, GuruFocus, Stock Beast, SmallCap Network, Stockhouse, and Promotion Stock Secrets reported earlier on Vitality Biopharma, Inc. (VBIO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s dedication is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, the Company has developed a unique capability to produce molecules via glycosylation. This is a form of enzymatic biosynthesis, which was originally developed to improve the taste of stevia. The platform is well suited for the discovery of new pharmaceutical products. OTCQB-listed, Vitality Biopharma has its headquarters in Los Angeles, California. 

Late in 2015, Vitality successfully modified cannabidiol (CBD), which is not psychoactive. In continuing work, the Company has created a novel class of pharmaceuticals called cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract.

Vitality Biopharma can biosynthesize cannabinoid glycosides (cannabosides) via enzyme biosynthesis. The Company is one of only a very few groups in the world who know how to produce and work with the enzymes that perform glycosylation. It has been focused on it because the same enzymes are used to modify the taste of stevia (steviol glycosides). 

Vitality Biopharma has developed a proprietary biosynthesis technology that can modify cannabinoids to create pharmaceutical prodrugs that have no psychoactivity and that can provide targeted disease treatment. The process involves small molecule glycosylation, where sugar molecules are attached to cannabinoids, creating new compounds called cannabinoid glycosides, or cannabosides.

The Company has introduced its lead cannabinoid drug formulation VITA-100 as a non-psychoactive prodrug of THC. Vitality is centering initial clinical development efforts on VITA-100, a proprietary THC cannabinoid drug formulation. The treatment indications it plans to evaluate in Phase 2 trials include inflammatory bowel disease (IBD), irritable bowel syndrome, and narcotic bowel syndrome (a severe form of opiate-induced abdominal pain).

Vitality Biopharma announced in April 2018 the pending establishment of a wholly-owned Canadian subsidiary, Vitality Genetics, Ltd. This subsidiary will focus on and enable the performance of a wide assortment of cannabinoid genetics research and development (R&D) programs.

Vitality Biopharma announced in May the discovery of new antimicrobial activity of cannabinoids and its application for treatment of C. difficile-associated diarrhea and colitis. In experiments executed according to guidance by the Clinical Laboratory and Standards Institute (CLSI), Vitality determined that cannabinoids (including THC) are effective antibiotics for C. diff, VRE, and a variety of additional pathogens.

Recently, Vitality Biopharma announced that during a recent in vitro safety pharmacological screening study, its lead drug candidate VBX-100 demonstrated no signs of adverse pharmacological effects. This affirms its potential for extensive clinical use as a GI-targeted prodrug of THC. Vitality Biopharma has filed for intellectual property (IP) protection on greater than 100 different glycoside prodrugs. This includes VBX-100.

Vitality Biopharma, Inc. (VBIO), closed Monday's trading session at $0.12, off by 7.6923%, on 11,230 volume with 15 trades. The average volume for the last 3 months is 23,596 and the stock's 52-week low/high is $1.04999995/$2.36999988.

chart

The Bon-Ton Stores, Inc. (BONTQ)

Penny Stock Hub, Zacks, Stockopedia, Investor Place, Investing.com, Stockflare, 4-Traders, InvestorsHub, StreetInsider, YCharts, Barchart, Stockhouse, and TradingView reported on The Bon-Ton Stores, Inc. (BONTQ), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets Group’s OTCQB and established in 1898, The Bon-Ton Stores, Inc. operates 250 stores. These include nine furniture galleries, in 23 states in the Northeast, Midwest and upper Great Plains under the Bon-Ton, Bergner's, Boston Store, Carson's, Elder-Beerman, Herberger's and Younkers nameplates. The Bon-Ton Stores has corporate headquarters in York, Pennsylvania and Milwaukee, Wisconsin.

The Company’s stores offer a wide variety of national and private brand fashion apparel and accessories for women, men and children. The stores also offer cosmetics and home furnishings.

The Bon-Ton Stores has been taking action over the past number of months to boost improved performance and strengthen its financial position. The Company has taken another step forward in its efforts through filing voluntary petitions for a court-supervised restructuring under Chapter 11.

On February 4, 2018, The Bon-Ton Stores, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Its varied stores throughout the U.S. are open. In addition, its e-commerce and mobile platforms are operating normally.

This week, The Bon-Ton Stores announced that it received a signed letter of intent (LOI) from an investor group consisting of DW Partners, Namdar Realty Group (including its partner Mason Asset Management) and Washington Prime Group. This investor group proposes to acquire The Bon-Ton Stores as a going concern in a Bankruptcy Court-supervised sale process.

The Bon-Ton Stores and this investor group are in the process of finalizing an asset purchase agreement in advance of an auction. The auction is now scheduled to be held on Monday, April 16, 2018.

Mr. Bill Tracy, The Bon-Ton Stores’ President and Chief Executive Officer, said, "We are pleased to have received this signed letter of intent and are advancing our discussions with the investor group to complete an asset purchase agreement as we proceed toward the court-supervised auction. With the help of our advisors, we will evaluate all qualified bids and are committed to maximizing value and pursuing the best path forward for the Company and our stakeholders.”

The Bon-Ton Stores, Inc. (BONTQ), closed Monday's trading session at $0.0199, up 25.1572%, on 4,428 volume with 4 trades. The average volume for the last 3 months is 7,814 and the stock's 52-week low/high is $0.0026/$0.084899999.

chart

The QualityStocks Company Corner

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Monday's trading session at $2.09, off by 4.5662%, on 2,265 volume with 9 trades. The average volume for the last 3 months is 4,849 and the stock's 52-week low/high is $1.03999996/$21.00.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) was featured today in the 420 with CNW by CannabisNewsWire. In a press conference on Wednesday, Tom Wolf, Pennsylvania Governor accompanied by Lt. Gov. John Fetterman, announced his support for the legalization of adult-use recreational marijuana. In his announcement, he included the final report from Lt. Governor John Fetterman’s statewide tour on recreational marijuana legalization. He also proposed the next steps to be taken after reviewing the input submitted by the citizens from the 67 counties who attended their listening sessions or reverted via their online platform.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Monday's trading session at $4.47, up 0.675676%, on 45,623 volume with 326 trades. The average volume for the last 3 months is 67,268 and the stock's 52-week low/high is $3.76999998/$16.25.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (ETST) was featured today in a publication from HempWireNews, examining how a related company signed an agreement with a Chinese partner allowing that Canadian company to grow and process industrial hemp on 17,000 acres in China. Pure Global Cannabis, the Canadian company, signed this agreement with a Chinese company called KMT-Hansa Corp. KMT currently holds licenses to grow and process hemp on 17,000 acres in China, and they are teaming up with Pure Global to pull it off.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Monday's trading session at $0.44, up 22.2222%, on 19,671 volume with 18 trades. The average volume for the last 3 months is 67,268 and the stock's 52-week low/high is $0.300999999/$2.45000004.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced expansion of its subsidiary, CBD Biotech, Inc., into six new countries and a new region of China via Shopee, its newest sales channel. To view the full press release, visit http://cnw.fm/K3M2j.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Monday's trading session at $0.27766, up 3.0852%, on 5,348 volume with 13 trades. The average volume for the last 3 months is 46,587 and the stock's 52-week low/high is $0.25/$1.25.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures, Inc. (NUGS) was featured today in the 420 with CNW by CannabisNewsWire. In a press conference on Wednesday, Tom Wolf, Pennsylvania Governor accompanied by Lt. Gov. John Fetterman, announced his support for the legalization of adult-use recreational marijuana. In his announcement, he included the final report from Lt. Governor John Fetterman’s statewide tour on recreational marijuana legalization. He also proposed the next steps to be taken after reviewing the input submitted by the citizens from the 67 counties who attended their listening sessions or reverted via their online platform.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Monday's trading session at $0.23, up 5.0708%, on 103,419 volume with 56 trades. The average volume for the last 3 months is 93,876 and the stock's 52-week low/high is $0.181799992/$4.05000019.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

In order to achieve market success, it’s imperative for a company to have a sense of place, both within the terms of the marketplace in which it’s competing and within the geocultural climate where its customers live and breathe every day. IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) growing a complement of products as a national cannabis holdings company within the recreational adult-use space shows that it knows where it stands and also that it has a prescient idea of where the industry’s road to success is leading. Also today, CannabisNewsWire released a report on the company detailing how the company recently announced impressive second-quarter financial results. To view the full article, visit http://cnw.fm/7rRUw.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Monday's trading session at $0.0389, up 4.5699%, on 396,588 volume with 54 trades. The average volume for the last 3 months is 264,321 and the stock's 52-week low/high is $0.032000001/$0.634559988.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announced its appointment of Dr. William Li as Strategic Advisor to the CEO. To view the full press release, visit http://nnw.fm/g5JQk.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $0.0096, up 39.1304%, on 2,684,790 volume with 94 trades. The average volume for the last 3 months is 4,869,677 and the stock's 52-week low/high is $0.006/$0.066100001.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0117, up 1.7391%, on 2,115,179 volume with 83 trades. The average volume for the last 3 months is 3,371,731 and the stock's 52-week low/high is $0.009999999/$0.039999999.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

In a global industry that reached $192.9 billion last year and saw a year-over-year increase of 1.5 percent from 2017 (http://nnw.fm/HQK0c), Sharing Services Global Corporation (OTCQB: SHRG) is ideally poised to benefit from a growing worldwide interest in direct sales.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.15, even for the day, on 13,000 volume with 1 trade. The average volume for the last 3 months is 33,719 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

CloudCommerce (OTCQB: CLWD)

The QualityStocks Daily Newsletter would like to spotlight CloudCommerce (OTCQB: CLWD).

For marketers, connecting with the consumers most likely to need their products is like finding that proverbial needle in a haystack. Consequently, a lot of digital marketing today operates on the timeworn spray-and-pray model or delivers “stalker ads” that surreptitiously pursue consumers from site to site, even though those consumers may have already purchased the product being advertised. Spray-and-pray is inefficient, since the model often serves up ads to the wrong markets. Stalker ads are equally ineffectual. In addition, they annoy viewers and are costly both in terms of dollars and distinctiveness for brands. Fortunately, solutions now being offered by CloudCommerce Inc. (OTCQB: CLWD) promise to provide a new promotional paradigm for marketers.

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.

Flagship Solution

SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.

Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.

The Market

Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.

However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.

In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.

SWARM Products

THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.

BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.

HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.

HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.

Subsidiaries

Data Propria
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.

Parscale Digital
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.

Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.

WebTegrity
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.

Leadership

Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.

Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.

Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.

Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.

CloudCommerce (OTCQB: CLWD), closed Monday's trading session at $0.0037, even for the day, on 3,031,400 volume. The average volume for the last 3 months is 918,601 and the stock's 52-week low/high is $0.003299999/$0.0228.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) new partnerships and its unique rebranding strategy.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $2.63, off by 6.7376%, on 83,791 volume with 188 trades. The average volume for the last 3 months is 35,737 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today in a report by HempWireNews, which examines how a related company, Pure Global Cannabis, recently signed an agreement with a Chinese partner allowing the Canadian company to grow and process industrial hemp on 17,000 acres in China.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $1.66, off by 2.3529%, on 523,644 volume with 1,194 trades. The average volume for the last 3 months is 106,416 and the stock's 52-week low/high is $1.44807004/$5.40999984.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced that its secured promissory notes that were due September 28, 2019 have been repaid or extended. On September 27, 2019, the Company repaid the remaining principal and interest balance of $478,590 on one of such notes. On the same date, the Company obtained a new investment of $700,000 from a private investor in exchange for a new 8% secured promissory note due on March 27, 2020 with an original principal amount of $847,500. The Company also issued 88,574 shares of common stock and a 682,368 share warrant to the new investor.

Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Predictive Oncology (POAI), closed Monday's trading session at $0.505, off by 14.4213%, on 99,569 volume with 100 trades. The average volume for the last 3 months is 52,574 and the stock's 52-week low/high is $0.419999986/$0.850000023.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

CBDWire released a report highlighting Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today, which examines the recent London event discussions led by Mark Tucker, the CEO of TTS Pharma. The experts during the event cautioned that a consumer may not suffer from a single exposure to those toxins, but health risks are more likely to arise over the years as people accumulate these toxins in their bodies. The success of the CBD industry may therefore depend on how regulators manage to draw a line between the use of CBD as a supplement or as a drug.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed Monday's trading session at $0.2496, off by 7.487%, on 8,923 volume with 11 trades. The average volume for the last 3 months is 10,055 and the stock's 52-week low/high is $0.249599993/$1.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.